← Eichor
Condition: Alcoholic Cirrhosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alcoholic Cirrhosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT05526144Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
Phase 3 · 11 location(s) · Pharmicell Co., Ltd. · NCT04689152Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821SAMe Trial for Patients With Alcoholic Cirrhosis
Phase 2 · 2 location(s) · Indiana University · NCT04250259Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT07169526The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Phase 4 · 1 location(s) · Getz Pharma · NCT05644717PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT04371042Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
Phase N/A · 1 location(s) · German Diabetes Center · NCT05046483InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From
Phase N/A · 1 location(s) · The Affiliated Hospital of Hangzhou Normal University · NCT07241195LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · 444 location(s) · Boehringer Ingelheim · NCT06632457Integrated Diagnostics for Early Diagnosis of Liver Disease
Phase N/A · 1 location(s) · Manchester University NHS Foundation Trust · NCT04666402Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
Phase N/A · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07658755An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
NA · 2 location(s) · Khyber Medical University Peshawar · NCT07294963Digoxin In NASH (CODIN)
Phase 2 · 2 location(s) · Yale University · NCT06588699Evaluating the Pharmacokinetics and Safety of Miricorilant
Phase 1 · 1 location(s) · Corcept Therapeutics · NCT07553663Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
NA · 13 location(s) · University Hospital, Angers · NCT05699018Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916Efficacy of Simvastatin in Alcoholic Liver Fibrosis
Phase 2/Phase 3 · 1 location(s) · Anna Cruceta · NCT04971577Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients W
Phase N/A · 9 location(s) · University Hospital, Lille · NCT04106518Biomarkers in the Diagnosis and Prognosis of NAFLD
Phase N/A · 1 location(s) · University of Trieste · NCT06098417
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.